We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns New York Drugmaker for Lack of Product Testing, Quality Unit
FDA Warns New York Drugmaker for Lack of Product Testing, Quality Unit
A lack of product testing and a deficient quality unit resulted in a warning letter for New York-based Scientific Solutions Global, in addition to unapproved new drug violations.